Cardiology. acute severe mitral regurgitation
Insights
Acute mitral regurgitation, a complication of myocardial infarction, has a poor prognosis without intervention. Surgical treatment, including mitral valve replacement, offers improved survival for these critically ill patients.
Area of Science:
- Cardiology
- Cardiac Surgery
Background:
- Acute mitral regurgitation (AMR) complicates myocardial infarction in approximately 1% of cases.
- Clinical presentation includes new systolic murmur, acute heart failure, hypotension, and shock.
- Prognosis is poor without timely intervention.
Purpose of the Study:
- To review the clinical findings, prognosis, and treatment of acute mitral regurgitation.
- To differentiate outcomes based on etiology (myocardial infarction vs. other causes).
Main Methods:
- Review of clinical characteristics and outcomes.
- Analysis of treatment strategies, including medical management and surgical intervention.
- Comparison of prognostic factors in AMR secondary to myocardial infarction versus other etiologies.
Main Results:
- Medical therapy offers temporary hemodynamic improvement but does not impact survival.
- Surgical mitral valve replacement, potentially with coronary revascularization, improves survival rates.
- AMR secondary to chordae tendineae rupture (non-coronary artery disease) has a better prognosis and surgical benefit.
Conclusions:
- Acute severe mitral regurgitation requires prompt diagnosis and management.
- Surgical intervention is crucial for improving survival in AMR.
- Etiology significantly influences patient outcomes and treatment decisions.
Abstract:
Acute mitral regurgitation occurs as a complication of myocardial infarction in perhaps 1% of cases. The characteristic clinical findings include a new systolic murmur occurring in the setting of sudden development of acute congestive heart failure, hypotension, and shock. S3 and S4 gallops and sinus rhythm usually are present, and gross left ventricular or left atrial enlargement usually is not evident radiologically. The immediate and long-term prognoses for patients with acute severe mitral regurgitation are poor without treatment. Although medical therapy can reverse temporarily some of the hemodynamic aberrations, it does not influence survival or eliminate the need for surgical treatment. Surgery consisting of mitral valve replacement and possibly simultaneous coronary revascularization appears to offer some hope in increasing the survival rate among these patients. When acute severe mitral regurgitation is secondary to rupture of chordae tendineae in circumstances other than coronary artery disease, the outlook is not as grim. These patients may show signs and symptoms of congestive heart failure for a few weeks or, at times, many months. Again, sinus rhythm usually is present, with slight left ventircular enlargement, a relatively normal left atrial size, and markedly elevated left atrial and pulmonary arterial pressures. This constellation of findings is indicative of a large mitral regurgitant flow with preservation of left ventricular function and suggests that the patient is likely to benefit greatly from surgical treatment. The prognosis for such patients is much better than it is for the patients with acute mitral regurgitation secondary to coronary artery disease.
More Related Videos
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests


